Carbetapentane / guaifenesin / pseudoephedrine Pregnancy and Breastfeeding Warnings
Brand names: Exall-D
Carbetapentane / guaifenesin / pseudoephedrine Pregnancy Warnings
Carbetapentane/guaifenesin/pseudoephedrine has been assigned to FDA pregnancy category C. Animal studies have not been reported. There are no controlled data in human pregnancy. The manufacturer recommends that carbetapentane/guaifenesin/pseudoephedrine not be administered to pregnant women.
Carbetapentane / guaifenesin / pseudoephedrine Breastfeeding Warnings
There are no data on the excretion of carbetapentane/guaifenesin/pseudoephedrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- (2009) "Product Information. Exall-D (carbetapentane/guaifenesin/pseudoephedrine)." Hawthorn Pharmaceuticals
References for breastfeeding information
- (2009) "Product Information. Exall-D (carbetapentane/guaifenesin/pseudoephedrine)." Hawthorn Pharmaceuticals
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
